| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.7M | -27.8% |
| R&D Expense | $378K | — |
| SG&A Expense | $1.9M | +40.6% |
| Operating Income | -$3.3M | -106.6% |
| Pre-tax Income | -$3.6M | -123.7% |
| Net Income | -$3.6M | -123.7% |
| EPS (Basic) | -$0.67 | -86.1% |
| EPS (Diluted) | -$0.67 | -86.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.3M | +332.7% |
| Accounts Receivable | $37K | +31.6% |
| Inventory | $4K | -93.2% |
| Current Assets | $2.5M | +306.1% |
| Total Assets | $3.7M | +234.6% |
| Current Liabilities | $606K | -25.6% |
| Long-term Debt | $149K | — |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.1M | -583.9% |
| Capital Expenditures | $13K | -7.8% |
| Investing Cash Flow | -$402K | -2685.2% |
| Financing Cash Flow | $5.2M | +550.9% |
| Free Cash Flow | -$3.1M | -565.5% |
| Total Liabilities |
| $1.1M |
| -8.1% |
| Stockholders' Equity | $2.6M | +2469.0% |